These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18846346)

  • 21. Viscous carbomer eye drops in patients with dry eyes. Efficacy and safety. A randomized, open, cross-over, multicentre study.
    Marner K; Møoller PM; Dillon M; Rask-Pedersen E
    Acta Ophthalmol Scand; 1996 Jun; 74(3):249-52. PubMed ID: 8828721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
    Davitt WF; Bloomenstein M; Christensen M; Martin AE
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome.
    Tauber J
    Curr Med Res Opin; 2007 Nov; 23(11):2629-36. PubMed ID: 17868503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.
    Albietz JM; Lenton LM; McLennan SG; Earl ML
    CLAO J; 2002 Apr; 28(2):96-100. PubMed ID: 12054380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of polyethylene covers versus carbomer drops (Viscotears) to prevent dry eye syndrome in the critically ill.
    Kocaçal Güler E; Eşer I; Eğrilmez S
    J Clin Nurs; 2011 Jul; 20(13-14):1916-22. PubMed ID: 21414053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
    Brignole F; Pisella PJ; Dupas B; Baeyens V; Baudouin C
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):531-8. PubMed ID: 15965673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyacrylic acid gel in patients with dry eyes: a randomised comparison with polyvinyl alcohol.
    Bron AJ; Mangat H; Quinlan M; Foley-Nolan A; Eustace P; Fsadni M; Sunder Raj P
    Eur J Ophthalmol; 1998; 8(2):81-9. PubMed ID: 9673476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
    Cömez AT; Tufan HA; Kocabıyık O; Gencer B
    Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear film normalization test: a new diagnostic test for dry eyes.
    Latkany R; Lock BG; Speaker M
    Cornea; 2006 Dec; 25(10):1153-7. PubMed ID: 17172889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Taufon use in myopic contact lens wearers].
    Naumenko VV; Pogosian MA; Sergeev VP
    Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations.
    Wang IJ; Lin IC; Hou YC; Hu FR
    Eur J Ophthalmol; 2007; 17(2):151-9. PubMed ID: 17415686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive, objective, multimodal tear dynamics evaluation of 5 over-the-counter tear drops in a randomized controlled trial.
    Tung CI; Kottaiyan R; Koh S; Wang Q; Yoon G; Zavislan JM; Davio SR; Aquavella JV
    Cornea; 2012 Feb; 31(2):108-14. PubMed ID: 22138585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Carbomer-Based Lipid-Containing Artificial Tear Formulations in Patients With Dry Eye Syndrome.
    Chung SH; Lim SA; Tchach H
    Cornea; 2016 Feb; 35(2):181-6. PubMed ID: 26509769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study.
    Sanchez MA; Torralbo-Jimenez P; Giron N; de la Heras B; Herrero Vanrell R; Arriola-Villalobos P; Diaz-Valle D; Alvarez-Barrientos A; Benitez-Del-Castillo JM
    Cornea; 2010 Feb; 29(2):167-71. PubMed ID: 20023577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of artificial tears on visual acuity.
    Nilforoushan MR; Latkany RA; Speaker MG
    Am J Ophthalmol; 2005 Nov; 140(5):830-5. PubMed ID: 16310460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.
    She Y; Li J; Xiao B; Lu H; Liu H; Simmons PA; Vehige JG; Chen W
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):525-30. PubMed ID: 26322539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.